Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Visually-guided laser may be viable treatment for abnormal heartbeat

26.05.2010
American Heart Association spokesperson, electrophysiologist Gordon Tomaselli, M.D., is available for comment on this study.
Study highlights:
A new treatment known as a visually guided balloon-laser catheter stopped abnormal electrical pulses in people and pigs with irregular heartbeats.

The intervention prevented abnormal impulses for three months.
Additional long-term studies are needed to assess ongoing safety and effectiveness.

A new treatment known as a visually-guided laser-balloon catheter successfully interrupted abnormal electrical pulses in patients and pigs with intermittent, irregular heartbeats, in a study reported in Circulation: Arrhythmia and Electrophysiology, a journal of the American Heart Association.

Severe cases of irregular heartbeat may require a procedure called ablation, which destroys a group of “misfiring” cells to stop abnormal electrical impulses that cause erratic heartbeats.

Investigators aimed at cells in the pulmonary veins that carry blood from the lungs to the heart. In the clinical part of the study, they ablated the misfiring cells with 100 percent accuracy. In 84 percent of the pulmonary veins treated, electrical pulses ceased after just one set of laser treatments. Three months after treatment, 90 percent of the treated veins remained inactive.

Unlike other catheters that rely on X-rays for visual guidance, in the new treatment doctors use a slender instrument called an endoscope that provides continuous real-time images. This allows investigators to aim the laser at precise locations in the pulmonary veins. The investigators destroyed cells in an overlapping pattern to completely “disconnect” them and prevent new electrical connections from forming later.

The study’s clinical component included 27 patients, average age 53, two-thirds male, with diagnosed intermittent, abnormal heartbeat (called paroxysmal atrial fibrillation, or PAF). All patients had tried at least one drug that did not relieve their symptoms.

For the animal model, the scientists examined pigs because their hearts are structured similar to humans. The investigators inactivated abnormally functioning pulmonary veins 97 percent of the time after the first set of laser-energy treatments. Four weeks later, 80 percent of the ablated veins were still inactive.

Additional research is needed to determine long-term safety and efficacy of balloon-guided, laser catheter, researchers said.

Author disclosures are on the manuscript. CardioFocus, Inc., funded the study.

Atrial Fibrillation facts and statistics

An estimated 2.2 million Americans are living with atrial fibrillation (AF).
It’s the most common “serious” heart rhythm abnormality in people over the age of 65 years.

11,438 deaths and 461,000 hospital discharges are attributed to AF per year, and about 75,000 new cases of AF are diagnosed each year.

Stroke is 5 times more likely in people with AF compared to those without the condition.

AF is responsible for at least 15% to 20% of all ischemic strokes.

Data from the NHDS/NCHS (1996 –2001) on cases that included AF as a primary discharge diagnosis found the following:

– Approximately 44.8% of patients were men.
– The mean age for men was 66.8 years, versus 74.6 years for women.
– The racial breakdown for admissions was 71.2% white, 5.6% black, and 2.0% other races (20.8% were not specified).

Symptoms of atrial fibrillation

Some people with AF don’t feel a thing. Others notice an irregularity immediately. Symptoms may include:
– Racing, uncomfortable, irregular heartbeat
– “Flopping,” fluttering or thumping feeling in your chest
– Heart palpitations
– Dizziness
– Sweating
– Chest pain or pressure
– Difficulty getting your breath
– Overall weakness
– Fainting
– Fatigue during exercise.
Visit the AF page at americanheart.org for more information on AF.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.americanheart.org/corporatefunding.

Maggie Francis | EurekAlert!
Further information:
http://www.heart.org

More articles from Medical Engineering:

nachricht 3-D visualization of the pancreas -- new tool in diabetes research
15.03.2017 | Umea University

nachricht New PET radiotracer identifies inflammation in life-threatening atherosclerosis
02.03.2017 | Society of Nuclear Medicine

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>